ServicenavigationHauptnavigationTrailKarteikarten


Research unit
INNOSUISSE
Project number
35796.1 IP-LS
Project title
Evaluate the Efficacy of a Drug Candidate for Amyotrophic Lateral Sclerosis (ALS)

Texts for this project

 GermanFrenchItalianEnglish
Short description
Anzeigen
-
-
Anzeigen
Abstract
Anzeigen
-
-
Anzeigen

Inserted texts


CategoryText
Short description
(German)
Evaluate the Efficacy of a Drug Candidate for Amyotrophic Lateral Sclerosis (ALS)
Short description
(English)
Evaluate the Efficacy of a Drug Candidate for Amyotrophic Lateral Sclerosis (ALS)
Abstract
(German)
SBC003 is a synthetic natural neuroprotective agent showing promising effects in Amyotrophic Lateral Sclerosis (ALS) models. The objective of this project is to further evaluate the efficacy and mode of action of SBC003 in both in vivo and in vitro ALS disease models.
Abstract
(English)